Investigating the utility of primary care skin cancer clinics in Queensland
调查昆士兰初级保健皮肤癌诊所的效用
基本信息
- 批准号:nhmrc : 339100
- 负责人:
- 金额:$ 12.47万
- 依托单位:
- 依托单位国家:澳大利亚
- 项目类别:NHMRC Project Grants
- 财政年份:2005
- 资助国家:澳大利亚
- 起止时间:2005-01-01 至 2006-12-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Skin cancer is the most common cancer in Australia, with an estimated 375,000 people being treated for some skin cancer in Australia in 2002, and 1462 dying from the disease (mainly from melanoma) in 2001. Australia has the highest rate of skin cancer, both melanoma and non-melanoma is the world. However, if detected early, skin cancer is curable, and the focus of current treatment programs internationally is to detect the disease before it progresses to an advanced stage. A large proportion of skin cancers are first detected by the non-medical community. However, due to the two-tiered medical system in Australia, a person first seeks medical opinion from a general practitioner (GP), who acts as a gatekeeper for further treatment from a specialist. Therefore the ability of GPs to be able to discern which lesions require further treatment is crucial, both for the patient, and the financial burden on the health system. A recent development has been the establishment of dedicated primary skin care clinics, which offer open access consultations to the community for the diagnosis and treatment of skin cancers and pigmented lesions. The emergence of these clinics has created much debate in the medical media. Concern has been expressed about the skills of practitioners in these clinics, whilst others argue that sub-specialisation in primary care will lead to improvements in the management of patients. As there is currently no data on the volume, casemix and diagnostic accuracy of these clinics it is difficult to assess the diagnostic ability of skin cancer clinics. This will be the first project to quantify the role of skin clinics in the diagnosis of skin cancer in the community, and in particular their case volume, casemix and diagnostic accuracy, and assess these measures in relation to a comparable sample of general practitioners. Queensland is an ideal location for a study of this type due to its high incidence of both types of skin cancer.
皮肤癌是澳大利亚最常见的癌症,2002年澳大利亚估计有375,000人因某些皮肤癌接受治疗,2001年有1462人死于这种疾病(主要是黑色素瘤)。澳大利亚皮肤癌发病率最高,黑色素瘤和非黑色素瘤均为世界第一。然而,如果及早发现,皮肤癌是可以治愈的,目前国际上治疗方案的重点是在疾病进展到晚期之前发现它。很大一部分皮肤癌首先是由非医学界发现的。然而,由于澳大利亚的两级医疗体系,人们首先向全科医生(GP)寻求医疗意见,全科医生充当专科医生进一步治疗的把关人。因此,全科医生辨别哪些病变需要进一步治疗的能力对于患者和卫生系统的经济负担至关重要。最近的一项进展是建立了专门的初级皮肤护理诊所,为社区提供开放式咨询,以诊断和治疗皮肤癌和色素性病变。这些诊所的出现在医学媒体上引起了很多争论。人们对这些诊所从业人员的技能表示担忧,而其他人则认为初级保健的亚专业化将改善患者的管理。由于目前没有这些诊所的数量、病例组合和诊断准确性的数据,因此很难评估皮肤癌诊所的诊断能力。这将是第一个量化皮肤诊所在社区皮肤癌诊断中的作用的项目,特别是其病例数量、病例组合和诊断准确性,并根据全科医生的可比样本评估这些措施。昆士兰州是进行此类研究的理想地点,因为这两种类型的皮肤癌的发病率都很高。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
A/Pr Philippa Youl其他文献
A/Pr Philippa Youl的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('A/Pr Philippa Youl', 18)}}的其他基金
Assessing the impact of geographical location and socioeconomics on clinical outcomes from breast cancer
评估地理位置和社会经济学对乳腺癌临床结果的影响
- 批准号:
nhmrc : 1054038 - 财政年份:2013
- 资助金额:
$ 12.47万 - 项目类别:
Early Career Fellowships
Understanding causes of the rising incidence of thyroid cancer – What can mutations in the BRAF oncogene tell us about causes and diagnostic pathways for thyroid cancer?
了解甲状腺癌发病率上升的原因 — BRAF 癌基因的突变可以告诉我们有关甲状腺癌的原因和诊断途径的哪些信息?
- 批准号:
nhmrc : 1047733 - 财政年份:2013
- 资助金额:
$ 12.47万 - 项目类别:
Project Grants
Randomized controlled trial of a video-delivered intervention for the early detection of melanoma in men 50+ years
视频干预对男性黑色素瘤早期检测 50 岁的随机对照试验
- 批准号:
nhmrc : 497200 - 财政年份:2008
- 资助金额:
$ 12.47万 - 项目类别:
NHMRC Project Grants
相似海外基金
Retaining relevance: extending clinical retention measures to improve their utility in describing HIV care engagement in the United States
保留相关性:扩大临床保留措施,以提高其在描述美国艾滋病毒护理参与方面的效用
- 批准号:
10759655 - 财政年份:2023
- 资助金额:
$ 12.47万 - 项目类别:
Evaluating the utility of adult-defined prognostic biomarkers in childhood onset primary chronic vasculitis
评估成人定义的预后生物标志物在儿童期发病的原发性慢性血管炎中的效用
- 批准号:
485919 - 财政年份:2022
- 资助金额:
$ 12.47万 - 项目类别:
Studentship Programs
Development of primary care clinical genetics: developing and assessing the clinical utility of a Japanese version of cancer risk assessment system in primary care (JCRAS-PC)
初级保健临床遗传学的发展:开发和评估日本版癌症风险评估系统在初级保健中的临床效用(JCRAS-PC)
- 批准号:
22K17326 - 财政年份:2022
- 资助金额:
$ 12.47万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Evaluating the utility of adult-defined prognostic biomarkers: Are they appropriate in childhood onset primary chronic vasculitis?
评估成人定义的预后生物标志物的效用:它们是否适合儿童期发病的原发性慢性血管炎?
- 批准号:
450994 - 财政年份:2021
- 资助金额:
$ 12.47万 - 项目类别:
Operating Grants
Clinical Utility of Biomarkers Driven Management of Indeterminate Pulmonary Nodules
生物标志物驱动的不确定肺结节管理的临床应用
- 批准号:
10398961 - 财政年份:2021
- 资助金额:
$ 12.47万 - 项目类别:
Food Delivery, Remote Monitoring, and coaching-Enhanced Education for Optimized Diabetes Management (FREEDOM)
食品配送、远程监控和辅导——优化糖尿病管理的强化教育(自由)
- 批准号:
10494295 - 财政年份:2021
- 资助金额:
$ 12.47万 - 项目类别:
Empirical testing of a widely available insurance-based monetary incentive program for exercise: A randomized trial
对广泛使用的基于保险的锻炼货币激励计划的实证检验:一项随机试验
- 批准号:
10278186 - 财政年份:2021
- 资助金额:
$ 12.47万 - 项目类别:
Identifying primary targets of bumped kinase inhibitor derived compounds to improve utility as therapy for castration resistant prostate cancer
确定碰撞激酶抑制剂衍生化合物的主要靶标,以提高治疗去势抵抗性前列腺癌的效用
- 批准号:
10317098 - 财政年份:2021
- 资助金额:
$ 12.47万 - 项目类别:
Impact of Mobile Manual Standing Wheelchair on Standing Dosage and Utility
移动手动站立轮椅对站立剂量和效用的影响
- 批准号:
10710376 - 财政年份:2021
- 资助金额:
$ 12.47万 - 项目类别:
Utility of Biomarkers of Rejection and Kidney Injury in Tailoring Liver Transplant Immunosuppression
排斥和肾损伤生物标志物在调整肝移植免疫抑制中的效用
- 批准号:
10651862 - 财政年份:2021
- 资助金额:
$ 12.47万 - 项目类别:














{{item.name}}会员




